What is Neogen's EBITDA?

Neogen (NEOG) reported EBITDA of $25.62M in Q4 2025.

How has Neogen's EBITDA changed year-over-year?

Neogen's EBITDA decreased by 26.3% year-over-year, from $34.75M to $25.62M.

What is the long-term trend for Neogen's EBITDA?

Over 4 years (2021 to 2025), Neogen's EBITDA has grown at a 77.3% compound annual growth rate (CAGR), from $95.21M to -$941.54M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Neogen NEOG EBITDA

EBITDA at other companies

Thermo Fisher ScientificTMO

——

Idexx LaboratoriesIDXX

——

ZoetisZTS

——

RevvityRVTY

——

TEC

Bio-TechneTECH

——

Agilent TechnologiesA

——

Other financials

Income statement

See full

Revenue$211.2M-4.4%

Gross profit$99.0M-10.2%

Operating income-$3.3M-161%

Net income-$17.0M-56.0%

EPS (diluted)-$0.08-60.0%

Balance sheet

See full

Cash & equivalents$159.9M+25.2%

Total debt$793.3M-11.2%

Total equity$2.1B-21.0%

Total assets$3.4B-16.8%

Cash flow

See full

Operating cash flow$22.7M+16.7%

CapEx$11.6M-64.7%

Free cash flow$11.1M+182%

Valuation

See full

Market cap$1.92B+12.0%

Enterprise value$2.56B+4.4%

P/S2.2×+0.3×

Profitability

See full

Gross margin45.2%-3.6pp

Operating margin-73.1%+77.7pp

Net margin-69.9%+30.8pp

FCF margin-14%—

Returns & leverage

See full

Return on equity-25.6%+28.8pp

Debt / equity0.4×0.0×

Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

−$3.3Mebit+

$28.9MDepreciation Depletion & Amortization

=$25.62M

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neogen's EBITDA?: Neogen (NEOG) reported EBITDA of $25.62M in Q4 2025.
How has Neogen's EBITDA changed year-over-year?: Neogen's EBITDA decreased by 26.3% year-over-year, from $34.75M to $25.62M.
What is the long-term trend for Neogen's EBITDA?: Over 4 years (2021 to 2025), Neogen's EBITDA has grown at a 77.3% compound annual growth rate (CAGR), from $95.21M to -$941.54M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.